Figure 4.
The immune-related signature can be predictive of survival of gastric cancer patients with different clinicopathological features. Kaplan-Meier curves of OS between the high- and low-risk groups for patients with (a) age > 65 and (b) age < 65; (c) female and (d) male; (e) G1-2 and (f) G3; (g) T1-2 and (h) T3-4; (i) N0 and (j) N1-3; (k) M0 and (l) M1; (m) stage I-II and (n) stage III-IV.